Mélissa Celinli

Market Access and Pricing Consultant

Melissa CELINLI has been a Market Access Consultant at CEMKA since October 2023.

Within CEMKA, she participates in the preparation and drafting of Transparency, Early access authorisation and pricing dossiers for various medications. She is also involved in the development and implementation of market access strategies.

Melissa actively contributes to regulatory monitoring concerning the French and European market access for medications.

Before joining CEMKA, Melissa spent a year in a pharmaceutical company (Roche), where she had the opportunity to work on the market access of innovative therapies in oncology-hematology and neurology. She also gained experience in the market access of medical devices.

She holds a PharmD and a Master’s degree in “Market Access and Health-Economic Evaluation” from Paris-Saclay University.